XENOREX

Welcome to the Brand page for “XENOREX”, which is offered here for Biochemicals, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases; and cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases;biochemicals, monoclonal antibodies and fragments thereof for research and development, and manufacturing pharmaceuticals; and cell lines for use in the manufacture of pharmaceuticals;animal embryos for laboratory use; and live animals for research and development;pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others;.

Its status is currently believed to be active. Its class is unavailable. “XENOREX” is believed to be currently owned by “Xenerex Biosciences”.


Owner:
XENEREX BIOSCIENCES
Owner Details
Description:
Biochemicals, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases; and cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases;Biochemicals, monoclonal antibodies and fragments thereof for research and development, and manufacturing pharmaceuticals; and cell lines for use in the manufacture of pharmaceuticals;Animal embryos for laboratory use; and live animals for research and development;Pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others;
Categories: BIOCHEMICALS